Central nervous system biomarkers GFAp and NfL associate with post-acute cognitive impairment and fatigue following critical COVID-19

A high proportion of patients with coronavirus disease 2019 (COVID-19) experience post-acute COVID-19, including neuropsychiatric symptoms. Objective signs of central nervous system (CNS) damage can be investigated using CNS biomarkers such as glial fibrillary acidic protein (GFAp), neurofilament li...

Descripción completa

Detalles Bibliográficos
Autores principales: Bark, Lovisa, Larsson, Ing-Marie, Wallin, Ewa, Simrén, Joel, Zetterberg, Henrik, Lipcsey, Miklos, Frithiof, Robert, Rostami, Elham, Hultström, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423244/
https://www.ncbi.nlm.nih.gov/pubmed/37573366
http://dx.doi.org/10.1038/s41598-023-39698-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423244/
https://www.ncbi.nlm.nih.gov/pubmed/37573366
http://dx.doi.org/10.1038/s41598-023-39698-y

Ejemplares similares